CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Telehealth and Mobile Services for Substance Use Disorder: Clinical Effectiveness, Cost-Effectiveness and Guidelines

Last updated: February 17, 2020
Project Number: RB1423-000
Product Line: Rapid Response
Research Type: Device
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of telehealth-delivered interventions and mobile (moveable) services in the management of substance use disorder?
  2. What is the cost-effectiveness of telehealth-delivered interventions and mobile (moveable) services in the management of substance use disorder?
  3. What are the evidence-based guidelines regarding telehealth-delivered interventions and mobile (moveable) services in the management of substance use disorder?

Key Message

Two systematic reviews and eight non-randomized studies were identified regarding the clinical effectiveness of telehealth-delivered interventions and mobile services in the management of substance use disorder. No relevant economic evaluations or evidence-based guidelines were identified regarding telehealth-delivered interventions and mobile (moveable) services in the management of substance use disorder. ​